Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus (Q64375454)

10

object named as

Anna Kanerva

0 references

author name string

Riikka Havunen

1

0 references

João M Santos

2

0 references

Suvi Sorsa

3

0 references

Tommi Rantapero

4

0 references

Dave Lumen

5

0 references

Mikko Siurala

6

0 references

Anu J Airaksinen

7

0 references

Victor Cervera-Carrascon

8

0 references

Siri Tähtinen

Molecular therapy oncolytics

9

0 references

language of work or name

English

0 references

publication date

21 December 2018

0 references

published in

0 references

volume

11

0 references

page(s)

109-121

0 references

cites work

Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly

1 reference

12 December 2020

Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells

1 reference

12 December 2020

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

1 reference

12 December 2020

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

1 reference

12 December 2020

Managing toxicities of high-dose interleukin-2.

1 reference

12 December 2020

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

1 reference

12 December 2020

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

1 reference

12 December 2020

Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection

1 reference

12 December 2020

WebGestalt: an integrated system for exploring gene sets in various biological contexts

1 reference

12 December 2020

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

1 reference

12 December 2020

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

1 reference

12 December 2020

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

1 reference

12 December 2020

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

12 December 2020

Tumour necrosis factor and cancer

1 reference

12 December 2020

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

1 reference

12 December 2020

Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus).

1 reference

12 December 2020

Use of allogeneic NK cells for cancer immunotherapy.

1 reference

12 December 2020

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

1 reference

12 December 2020

Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus

1 reference

12 December 2020

Immunologic correlates of the abscopal effect in a patient with melanoma

1 reference

12 December 2020

On the origin of cancer metastasis

1 reference

12 December 2020

Adoptive T-cell transfer in melanoma

1 reference

12 December 2020

Combining radiotherapy and cancer immunotherapy: a paradigm shift

1 reference

12 December 2020

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma

1 reference

12 December 2020

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

1 reference

12 December 2020

Trimmomatic: a flexible trimmer for Illumina sequence data

1 reference

12 December 2020

Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells

1 reference

12 December 2020

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways

1 reference

12 December 2020

Gene: a gene-centered information resource at NCBI.

1 reference

12 December 2020

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities.

1 reference

12 December 2020

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

1 reference

12 December 2020

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy

1 reference

12 December 2020

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

1 reference

12 December 2020

Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor

1 reference

12 December 2020

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

1 reference

12 December 2020

Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors

1 reference

12 December 2020

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

1 reference

12 December 2020

Human breast cancer cells educate macrophages toward the M2 activation status

1 reference

12 December 2020

TNF Counterbalances the Emergence of M2 Tumor Macrophages

1 reference

12 December 2020

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

1 reference

12 December 2020

Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study.

1 reference

12 December 2020

Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers.

1 reference

12 December 2020

MultiQC: summarize analysis results for multiple tools and samples in a single report.

1 reference

12 December 2020

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

1 reference

12 December 2020

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting

1 reference

12 December 2020

T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma

1 reference

12 December 2020

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

1 reference

12 December 2020

Database Resources of the National Center for Biotechnology Information.

1 reference

12 December 2020

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy

1 reference

12 December 2020

Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy

1 reference

12 December 2020

Local Delivery of OncoVEX(mGM-CSF) Generates Systemic Anti-Tumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade

1 reference

12 December 2020

Identification of essential genes for cancer immunotherapy.

1 reference

12 December 2020

Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer

1 reference

12 December 2020